rs140425210

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_000501.4(ELN):​c.1828G>A​(p.Gly610Ser) variant causes a missense change. The variant allele was found at a frequency of 0.000521 in 1,609,756 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0026 ( 3 hom., cov: 32)
Exomes 𝑓: 0.00030 ( 0 hom. )

Consequence

ELN
NM_000501.4 missense

Scores

2
16

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 4.92

Publications

11 publications found
Variant links:
Genes affected
ELN (HGNC:3327): (elastin) This gene encodes a protein that is one of the two components of elastic fibers. Elastic fibers comprise part of the extracellular matrix and confer elasticity to organs and tissues including the heart, skin, lungs, ligaments, and blood vessels. The encoded protein is rich in hydrophobic amino acids such as glycine and proline, which form mobile hydrophobic regions bounded by crosslinks between lysine residues. Degradation products of the encoded protein, known as elastin-derived peptides or elastokines, bind the elastin receptor complex and other receptors and stimulate migration and proliferation of monocytes and skin fibroblasts. Elastokines can also contribute to cancer progression. Deletions and mutations in this gene are associated with supravalvular aortic stenosis (SVAS) and autosomal dominant cutis laxa. [provided by RefSeq, Aug 2017]
ELN Gene-Disease associations (from GenCC):
  • cutis laxa, autosomal dominant 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, Ambry Genetics, Genomics England PanelApp, G2P
  • supravalvular aortic stenosis
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae)
  • autosomal dominant cutis laxa
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • familial thoracic aortic aneurysm and aortic dissection
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.009562254).
BP6
Variant 7-74063194-G-A is Benign according to our data. Variant chr7-74063194-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 226631.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00262 (399/152018) while in subpopulation AFR AF = 0.00914 (379/41466). AF 95% confidence interval is 0.00838. There are 3 homozygotes in GnomAd4. There are 196 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 399 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ELNNM_000501.4 linkc.1828G>A p.Gly610Ser missense_variant Exon 27 of 33 ENST00000252034.12 NP_000492.2 P15502-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ELNENST00000252034.12 linkc.1828G>A p.Gly610Ser missense_variant Exon 27 of 33 1 NM_000501.4 ENSP00000252034.7 P15502-2

Frequencies

GnomAD3 genomes
AF:
0.00263
AC:
399
AN:
151898
Hom.:
3
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00917
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000721
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00318
Gnomad NFE
AF:
0.0000588
Gnomad OTH
AF:
0.00192
GnomAD2 exomes
AF:
0.000697
AC:
168
AN:
240874
AF XY:
0.000493
show subpopulations
Gnomad AFR exome
AF:
0.00926
Gnomad AMR exome
AF:
0.000446
Gnomad ASJ exome
AF:
0.000207
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000549
Gnomad OTH exome
AF:
0.000343
GnomAD4 exome
AF:
0.000302
AC:
440
AN:
1457738
Hom.:
0
Cov.:
33
AF XY:
0.000262
AC XY:
190
AN XY:
724480
show subpopulations
African (AFR)
AF:
0.00884
AC:
296
AN:
33474
American (AMR)
AF:
0.000680
AC:
30
AN:
44122
Ashkenazi Jewish (ASJ)
AF:
0.000348
AC:
9
AN:
25852
East Asian (EAS)
AF:
0.000101
AC:
4
AN:
39628
South Asian (SAS)
AF:
0.0000355
AC:
3
AN:
84598
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53076
Middle Eastern (MID)
AF:
0.000868
AC:
5
AN:
5762
European-Non Finnish (NFE)
AF:
0.0000333
AC:
37
AN:
1110986
Other (OTH)
AF:
0.000930
AC:
56
AN:
60240
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
30
59
89
118
148
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00262
AC:
399
AN:
152018
Hom.:
3
Cov.:
32
AF XY:
0.00264
AC XY:
196
AN XY:
74272
show subpopulations
African (AFR)
AF:
0.00914
AC:
379
AN:
41466
American (AMR)
AF:
0.000720
AC:
11
AN:
15270
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5152
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4770
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10612
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.0000589
AC:
4
AN:
67964
Other (OTH)
AF:
0.00190
AC:
4
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.536
Heterozygous variant carriers
0
20
40
61
81
101
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000696
Hom.:
1
Bravo
AF:
0.00300
ESP6500AA
AF:
0.00908
AC:
40
ESP6500EA
AF:
0.000116
AC:
1
ExAC
AF:
0.000816
AC:
99
Asia WGS
AF:
0.000866
AC:
3
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jan 02, 2017
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 19, 2021
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 23401415) -

Supravalvar aortic stenosis Benign:2
Jan 06, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 28, 2017
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -

not specified Benign:1
Feb 15, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

p.Gly610Ser in exon 27 of ELN: This variant is not expected to have clinical sig nificance because it has been identified in 1.1% (90/7766) of African chromosome s from a broad population by the NHLBI Exome Sequencing Project (http://evs.gs.w ashington.edu/EVS; dbSNP rs140425210). -

Cutis laxa, autosomal dominant 1 Benign:1
Apr 28, 2017
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.22
BayesDel_addAF
Benign
-0.34
T
BayesDel_noAF
Benign
-0.25
CADD
Benign
23
DANN
Benign
0.95
DEOGEN2
Benign
0.16
T;T;.;T;T;.;.;.;.;T;.;.;.;.;.
Eigen
Benign
-0.0078
Eigen_PC
Benign
-0.12
FATHMM_MKL
Benign
0.39
N
LIST_S2
Benign
0.43
T;T;T;T;T;T;T;T;T;T;T;T;T;T;T
MetaRNN
Benign
0.0096
T;T;T;T;T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Benign
-0.94
T
MutationAssessor
Benign
1.7
.;.;.;L;.;.;.;.;.;.;.;.;.;.;.
PhyloP100
4.9
PrimateAI
Uncertain
0.62
T
PROVEAN
Benign
-1.8
N;.;N;D;N;N;N;N;N;N;N;N;N;N;N
REVEL
Benign
0.10
Sift
Benign
0.34
T;.;T;D;D;T;.;T;T;D;D;T;.;D;D
Sift4G
Uncertain
0.047
D;D;T;D;D;T;T;T;D;T;T;T;T;D;T
Polyphen
0.97
D;D;D;.;D;D;D;D;D;D;D;D;D;D;.
Vest4
0.40
MVP
0.75
MPC
0.18
ClinPred
0.032
T
GERP RS
3.8
Varity_R
0.067
gMVP
0.49
Mutation Taster
=95/5
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs140425210; hg19: chr7-73477524; API